Skip to content
Home/Companies/Healthcare / Biotech/Ablynx NV

Ablynx NV

Healthcare / Biotech·Belgium·Exited 2018·Held 10yr
Entry
2008
Hold
10yr
Exit
2018

Who owns Ablynx NV?

Ablynx NV was owned by Sofinnova Partners through Sofinnova Capital VI (2008 vintage) from 2008 to 2018, exited via Trade Sale.

Buyer identity available on Pro.

Hand-verified · updated 2026-04-21

Sofinnova Partners
Investor
Sofinnova Partners
Sofinnova Capital VI · 2008 · Life Sciences VC

Key facts

HQBelgium
SectorHealthcare / Biotech
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2018

More from Sofinnova Capital VI

Other portfolio companies in the same fund.

ABIONYX Pharma
Exited 2020
BiotechFrance· 2010
DBV
Exited 2014
BiotechFrance· 2010
Omthera Pharmaceuticals
Exited 2013
BiotechUS· 2010
to
Addex Therapeutics
Exited 2012
BiotechSwitzerland· 2008
Movetis
Exited 2010
BiotechBelgium· 2008
to
Noxxon Pharma
Exited 2016
BiotechGermany· 2008

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS
Track Ablynx NV

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on Ablynx NV.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue